These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
663 related articles for article (PubMed ID: 34267518)
1. Nanomaterials-Based Photodynamic Therapy with Combined Treatment Improves Antitumor Efficacy Through Boosting Immunogenic Cell Death. Jin F; Liu D; Xu X; Ji J; Du Y Int J Nanomedicine; 2021; 16():4693-4712. PubMed ID: 34267518 [TBL] [Abstract][Full Text] [Related]
2. Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy. Gao J; Wang WQ; Pei Q; Lord MS; Yu HJ Acta Pharmacol Sin; 2020 Jul; 41(7):986-994. PubMed ID: 32317755 [TBL] [Abstract][Full Text] [Related]
3. Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy. Ji B; Wei M; Yang B Theranostics; 2022; 12(1):434-458. PubMed ID: 34987658 [TBL] [Abstract][Full Text] [Related]
4. Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future. Alzeibak R; Mishchenko TA; Shilyagina NY; Balalaeva IV; Vedunova MV; Krysko DV J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33431631 [TBL] [Abstract][Full Text] [Related]
5. Expanded ROS Generation and Hypoxia Reversal: Excipient-free Self-assembled Nanotheranostics for Enhanced Cancer Photodynamic Immunotherapy. Yang J; Ren B; Yin X; Xiang L; Hua Y; Huang X; Wang H; Mao Z; Chen W; Deng J Adv Mater; 2024 Jul; 36(30):e2402720. PubMed ID: 38734937 [TBL] [Abstract][Full Text] [Related]
6. Emerging photodynamic nanotherapeutics for inducing immunogenic cell death and potentiating cancer immunotherapy. Zhang S; Wang J; Kong Z; Sun X; He Z; Sun B; Luo C; Sun J Biomaterials; 2022 Mar; 282():121433. PubMed ID: 35202933 [TBL] [Abstract][Full Text] [Related]
7. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy. Ni K; Luo T; Nash GT; Lin W Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760 [TBL] [Abstract][Full Text] [Related]
8. Smart Nanovesicle-Mediated Immunogenic Cell Death through Tumor Microenvironment Modulation for Effective Photodynamic Immunotherapy. Yang W; Zhang F; Deng H; Lin L; Wang S; Kang F; Yu G; Lau J; Tian R; Zhang M; Wang Z; He L; Ma Y; Niu G; Hu S; Chen X ACS Nano; 2020 Jan; 14(1):620-631. PubMed ID: 31877023 [TBL] [Abstract][Full Text] [Related]
9. Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency. Li Z; Lai X; Fu S; Ren L; Cai H; Zhang H; Gu Z; Ma X; Luo K Adv Sci (Weinh); 2022 Aug; 9(22):e2201734. PubMed ID: 35652198 [TBL] [Abstract][Full Text] [Related]
10. 5-ALA mediated photodynamic therapy with combined treatment improves anti-tumor efficacy of immunotherapy through boosting immunogenic cell death. Sun Z; Zhao M; Wang W; Hong L; Wu Z; Luo G; Lu S; Tang Y; Li J; Wang J; Zhang Y; Zhang L Cancer Lett; 2023 Feb; 554():216032. PubMed ID: 36493899 [TBL] [Abstract][Full Text] [Related]
11. Light-triggered photodynamic nanomedicines for overcoming localized therapeutic efficacy in cancer treatment. Choi J; Sun IC; Sook Hwang H; Yeol Yoon H; Kim K Adv Drug Deliv Rev; 2022 Jul; 186():114344. PubMed ID: 35580813 [TBL] [Abstract][Full Text] [Related]
12. Progress in advanced nanotherapeutics for enhanced photodynamic immunotherapy of tumor. Wei X; Song M; Jiang G; Liang M; Chen C; Yang Z; Zou L Theranostics; 2022; 12(12):5272-5298. PubMed ID: 35910806 [TBL] [Abstract][Full Text] [Related]
13. Enhancing cancer immunotherapy with photodynamic therapy and nanoparticle: making tumor microenvironment hotter to make immunotherapeutic work better. Thiruppathi J; Vijayan V; Park IK; Lee SE; Rhee JH Front Immunol; 2024; 15():1375767. PubMed ID: 38646546 [TBL] [Abstract][Full Text] [Related]
14. Redox-Activated Porphyrin-Based Liposome Remote-Loaded with Indoleamine 2,3-Dioxygenase (IDO) Inhibitor for Synergistic Photoimmunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway. Liu D; Chen B; Mo Y; Wang Z; Qi T; Zhang Q; Wang Y Nano Lett; 2019 Oct; 19(10):6964-6976. PubMed ID: 31518149 [TBL] [Abstract][Full Text] [Related]
15. Nanomedicine to aid immunogenic cell death (ICD)-based anticancer therapy. Demuynck R; Engelen Y; Skirtach AG; De Smedt SC; Lentacker I; Krysko DV Trends Cancer; 2024 Jun; 10(6):486-489. PubMed ID: 38553361 [TBL] [Abstract][Full Text] [Related]
17. Nanoparticle-Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy. Angew Chem Int Ed Engl; ; . PubMed ID: 30016571 [TBL] [Abstract][Full Text] [Related]